212 related articles for article (PubMed ID: 33050937)
1. Prognosis of papillary thyroid cancer in patients with Graves' disease: a propensity score-matched analysis.
Kwon H; Moon BI
World J Surg Oncol; 2020 Oct; 18(1):266. PubMed ID: 33050937
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
You E; Mascarella MA; Al Jassim A; Forest VI; Hier MP; Tamilia M; Pusztaszeri M; Payne RJ
J Otolaryngol Head Neck Surg; 2019 Aug; 48(1):40. PubMed ID: 31462328
[TBL] [Abstract][Full Text] [Related]
3. Graves' disease and papillary thyroid carcinoma: case report and literature review of a single academic center.
Arosemena MA; Cipriani NA; Dumitrescu AM
BMC Endocr Disord; 2022 Aug; 22(1):199. PubMed ID: 35945543
[TBL] [Abstract][Full Text] [Related]
4. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
[No Abstract] [Full Text] [Related]
7. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
[TBL] [Abstract][Full Text] [Related]
8. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.
Pellegriti G; Mannarino C; Russo M; Terranova R; Marturano I; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 2013 Mar; 98(3):1014-21. PubMed ID: 23348395
[TBL] [Abstract][Full Text] [Related]
9. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
[TBL] [Abstract][Full Text] [Related]
10. [Oncological alertness in Graves disease].
Ryabchenko EV
Khirurgiia (Mosk); 2023; (6):56-61. PubMed ID: 37313702
[TBL] [Abstract][Full Text] [Related]
11. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
Ryu YJ; Cho JS; Park MH; Yoon JH
BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
[TBL] [Abstract][Full Text] [Related]
12. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism.
Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L
BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715
[TBL] [Abstract][Full Text] [Related]
14. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.
Kuba S; Yamanouchi K; Hayashida N; Maeda S; Adachi T; Sakimura C; Kawakami F; Yano H; Matsumoto M; Otsubo R; Sato S; Fujioka H; Kuroki T; Nagayasu T; Eguchi S
Int J Surg; 2017 Feb; 38():143-148. PubMed ID: 27677707
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes of robotic thyroidectomy: 5-year experience with propensity score matching.
Tae K; Song CM; Ji YB; Sung ES; Jeong JH; Kim DS
Surg Endosc; 2016 Nov; 30(11):4785-4792. PubMed ID: 26895921
[TBL] [Abstract][Full Text] [Related]
16. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study.
Yoon JH; Jin M; Kim M; Hong AR; Kim HK; Kim BH; Kim WB; Shong YK; Jeon MJ; Kang HC
Endocrinol Metab (Seoul); 2021 Dec; 36(6):1268-1276. PubMed ID: 34823306
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for recurrent disease in small papillary thyroid cancers - a Swedish register-based study.
Bayadsi H; Nylén C; Sandström M; Angelsten J; Sund M; Hennings J
Langenbecks Arch Surg; 2023 Apr; 408(1):162. PubMed ID: 37099203
[TBL] [Abstract][Full Text] [Related]
20. Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
Premoli P; Tanda ML; Piantanida E; Veronesi G; Gallo D; Masiello E; Rosetti S; Cusini C; Boi F; Bulla J; Rodia R; Mariotti S; Capelli V; Rotondi M; Magri F; Chiovato L; Rocchi R; Campopiano MC; Elisei R; Vitti P; Barbato F; Pilli T; Castagna MG; Pacini F; Bartalena L
J Endocrinol Invest; 2020 Jan; 43(1):109-116. PubMed ID: 31327128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]